SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-045254
Filing Date
2022-08-10
Accepted
2022-08-10 17:19:12
Documents
1
Period of Report
2022-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3352
  Complete submission text file 0001209191-22-045254.txt   4790
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O REZOLUTE, INC. 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address
Miller Seline E. (Reporting) CIK: 0001769866 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51173 | Film No.: 221152792